Interleukin-4 prevents mortality from acute but not chronic murine peritonitis and induces an accelerated tumor necrosis factor-α response

European Surgical Research

Volumn 28, Issue 2, 1996, Pages 119-123

  Sawyer, R G ^a   Rosenlof, Lynn K ^b   Pruett, T L ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Interleukin 4; Peritonitis; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECT; MALE; METABOLISM; MORTALITY; MOUSE; PERITONITIS; SURVIVAL RATE; ANIMAL EXPERIMENT; ANIMAL MODEL; BACTEROIDES FRAGILIS; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; ANALYSIS OF VARIANCE; ANIMALS; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; PERITONITIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029661494     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129448     Document Type: Article

References (16)

1. Bohnen JMA, Mustard RA, Oxholm SE. Schoutcn BD: APACHE II score and abdominal sepsis. A prospective study. Arch Surg 1988; 123:225-229.
2. Jansen JH, Fibbe WE, Willemze R, Kluin-Nelemans JC: Interlcukin-4. A regulatory protein. Blut 1990:60: 269-274.
3. Paul WE: Interleukin-4: A prototypic immunoregulatory lymphokine. Blood 1991;77:1859-1870.
4. te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CJ: Interleukin-4 (1L-4) inhibits secretion of IL-1β, tumor necrosis factor u. and IL-6 by human monocytes. Blood 1990:76: 1392-1397.
5. Peleman R, Wu J. Fargeas C, Deles-pesse G: Recombinant interleukin-4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med 1989:170: 1751-1756.
6. Bogdan C, Nathan C: Modulation of macrophage function by transforming growth factor beta, intcrleukin-4, and interleukin-10. Ann NY Acad Sei 1993;685:713-739.
7. Hart PH, Cooper RL, Finlay-Jones JJ: 11,-4 suppresses IL-IS, TNF-u, and PGE2 production by human peritoneal macrophages. Immunology 1991:72:344-349.
8. Powrie F, Menon S, Coffman RL: Interlcukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993:23:3043-3049.
9. Sawyer RG, Adams RB, Spengler MD, Pruett TL: Preexposure of the peritoneum to live bacteria increases later mixed intraabdominal abscess formation and delays mortality. J Infect Dis 1991:163:664-667.
10. Phillips WA, Croatto M, Hamilton JA: Priming the macrophage respiratory burst with IL-4: Enhancement with TNF-α but inhibition by interferon-γ. Immunology 1990:70: 498-503.
11. Tracey KJ, Fong Y, Hesse DG, Manogue KR. Lee AT, Kuo GC, Lowry SF, Cerami A: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bactcracmia. Nature 1987;330:662-664.
12. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (in-tcrleukins-I and -6 tumor necrosis factor). Circ Shock 1992:36:191-199.
13. Sheppard BC, Fraker DL, Norton JA: Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery 1989; 106:156-161.
14. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH: The complex pattern of cytokines in sepsis. Association between prostaglandins, cachcctin. and interleukins. Ann Surg 1991;214:141-148.
15. Hamilton G, Hofbauer S, Hamilton B: Endotoxin TNF-α, interlcukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand J Infect Dis 1992;24:361-368.
16. Weinstein WM, Ondcrdonk AB, Bartlett JB, Gorbach SL: Experimental intra-abdominal abscesses in rats: Development of an experimental model. Infect Immun 1974:10: 1250-1255.